Taiwan Mundipharma Pharmaceuticals Ltd. clinical trials
A country office of Mundipharma
The registry lists 5 studies whose lead sponsor is Taiwan Mundipharma Pharmaceuticals Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 20, 2020.
Registry sponsor names on this page
- Taiwan Mundipharma Pharmaceuticals Ltd.5 studies
Something wrong with this grouping? Tell us on the Mundipharma page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Mundipharma studies →
- Safety and Effectiveness of Transdermal Buprenorphine in Cancer PainCompletedNCT04315831
Sponsor listed in the registry: Taiwan Mundipharma Pharmaceuticals Ltd.
- Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176121Phase 4
Sponsor listed in the registry: Taiwan Mundipharma Pharmaceuticals Ltd.
- A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176199Phase 4
Sponsor listed in the registry: Taiwan Mundipharma Pharmaceuticals Ltd.
- Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsStatus unknownNCT03155516Not applicable
Sponsor listed in the registry: Taiwan Mundipharma Pharmaceuticals Ltd.
- A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior TherapyStatus unknownNCT03150602Phase 4
Sponsor listed in the registry: Taiwan Mundipharma Pharmaceuticals Ltd.